Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is one of the stocks on Jim Cramer’s radar recently. When Cramer was asked about the ...

Detailed price information for Silence Therapeutics Plc ADR (SLN-Q) from The Globe and Mail including charting and trades.

Incyte posts strong Q3 results as higher sales of Jakafi, Opzelura and new launches drive revenue and earnings beats.

Incyte on Tuesday raised its annual sales forecast for Jakafi after the cancer drug helped the company post third-quarter results above Wall Street estimates.

Incyte (INCY) reported a breakout quarter on Oct. 28, beating Wall Street’s revenue and earnings estimates. Best known for ...

Disc Medicine is planning to launch a trial by year's end to test DISC-3405, its treatment candidate for iron overload, in ...

Drugmaker Incyte Corp on Tuesday raised its annual sales forecast for its blood cancer treatment Jakafi after robust demand for the drug helped the company surpass Wall Street estimates for ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

A doer, motivator, creator and adventurer, Meredith will be best remembered as upbeat, outspoken and confident, with a remarkable drive to excel at anything she did.

NORRIDGEWOCK – After a hard-fought and painful battle with Polycythemia Vera, a rare bone marrow disease, Craig Lee Judd passed on … NORRIDGEWOCK – After a hard-fought and painful battle with ...

Incyte (Nasdaq:INCY) today reported financial results for the third quarter of 2025 and provided a business update.